The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Tecogen Inc (AMEX: TGEN) was $6.03 for the day, down -6.80% from the previous closing price of $6.47. In other words, the price has decreased by -$6.80 from its previous closing price. On the day, 0.53 million shares were traded. TGEN stock price reached its highest trading level at $6.7 during the session, while it also had its lowest trading level at $5.88.
Ratios:
Our analysis of TGEN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.91 and its Current Ratio is at 2.71. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In the most recent recommendation for this company, Roth Capital on August 18, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 03 ’25 when Lafaille Stephen bought 400 shares for $2.50 per share. The transaction valued at 1,000 led to the insider holds 400 shares of the business.
Lafaille Stephen sold 25,000 shares of TGEN for $149,500 on Jun 06 ’25. The VP of Business Development now owns 400 shares after completing the transaction at $5.98 per share. On Jun 04 ’25, another insider, Lafaille Stephen, who serves as the VP of Business Development of the company, sold 15,000 shares for $5.00 each. As a result, the insider received 75,000 and left with 400 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TGEN now has a Market Capitalization of 179974288 and an Enterprise Value of 167422400. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.47 while its Price-to-Book (P/B) ratio in mrq is 7.06. Its current Enterprise Value per Revenue stands at 6.016 whereas that against EBITDA is -39.176.
Stock Price History:
The Beta on a monthly basis for TGEN is 1.26, which has changed by 2.7398844 over the last 52 weeks, in comparison to a change of 0.13613915 over the same period for the S&P500. Over the past 52 weeks, TGEN has reached a high of $12.07, while it has fallen to a 52-week low of $1.28. The 50-Day Moving Average of the stock is -24.88%, while the 200-Day Moving Average is calculated to be -2.05%.
Shares Statistics:
TGEN traded an average of 736.54K shares per day over the past three months and 397880 shares per day over the past ten days. A total of 29.82M shares are outstanding, with a floating share count of 18.16M. Insiders hold about 39.34% of the company’s shares, while institutions hold 25.89% stake in the company. Shares short for TGEN as of 1764288000 were 2096647 with a Short Ratio of 2.85, compared to 1761868800 on 1406262. Therefore, it implies a Short% of Shares Outstanding of 2096647 and a Short% of Float of 9.83.
